Testing version — LOERadar is in active testing. Features and data may change.
ZANVASTRO (ZILGANERSEN SODIUM) | LOERadar
Not in the current Orange Book — This application is not listed in FDA's current Orange Book data files (no listed patents or exclusivities). Product and approval data shown are from FDA's Drugs@FDA database.
ZANVASTRO
NDANot in Orange Book
ZILGANERSEN SODIUM | N220210 | IONIS PHARMS INC
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — EQ 56MG BASE/2.8ML (EQ 20MG BASE/ML)
▴
SOLUTION;INTRATHECAL | Approved: Sep. 3, 2026
Patents (1) · 1 use code
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
11786546Newly listed — daily FDA feed, not yet in monthly Orange Book edition